Outcome of renal transplantation in hepatitis B surface antigen-positive patients after introduction of lamivudine

Nephrology Dialysis Transplantation

Volumn 16, Issue 11, 2001, Pages 2222-2228

  Park, Su Kil ^a   Yang, Won Seok ^a   Lee, Yung Sang ^a   Jung, Hae Hyuk ^a   Chang, Jai Won ^a   Choi, Hye Jeong ^a   Han, Duck Jong ^a   Park, Jung Sik ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Hepatitis B; Lamivudine; Liver biopsy; Prognosis; Renal Transplantation

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; LIVER ENZYME; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; PREDNISONE; VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; CADAVER DONOR; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG TOLERABILITY; FEMALE; GRAFT REJECTION; HEPATITIS B; HEPATITIS B VIRUS; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVER BIOPSY; LIVER DYSFUNCTION; LIVER FUNCTION TEST; LIVING DONOR; MALE; PRIORITY JOURNAL; RECIPIENT; RELAPSE; RETROSPECTIVE STUDY; SIDE EFFECT; VIRUS REPLICATION;

EID: 0035158952     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.11.2222     Document Type: Article

References (20)

1. Value of liver biopsy in the evaluation and management of chronic liver disease in renal transplant recipients
2. The evaluation of renal transplant candidates: Clinical practice guidelines
3. Chronic hepatitis in end-stage renal disease: Comparison of HBsAg-negative and HBsAg-positive patients
4. Impact of hepatitis B and C virus on kidney transplantation outcome
5. Antiviral therapy in chronic hepatitis B infection
6. Interferon-α-induced acute renal allograft rejection
7. A preliminary trial of lamivudine for chronic hepatitis B infection
8. Beneficial effect of lamivudine in recurrent hepatitis B after liver transplantation
9. Efficacy and safety of lamivudine on replication of recurrent hepatitis B after cadaveric renal transplantation
10. Treatment of chronic hepatitis B with lamivudine in renal transplant recipients
11. Twelve months of lamivudine treatment for chronic hepatitis B virus infection in renal transplant recipients
12. The nomenclature of chronic active hepatitis: An obituary
13. Hepatitis B and transplantation
14. The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection
15. The increased risk of fatal liver disease in renal transplant patients who are hepatitis B antigen and/or HBV DNA positive
16. Hepatitis B liver disease in cyclosporine-treated renal allograft recipients
17. T cell mechanisms in the immunopathogenesis of viral hepatitis B and C
18. Clinical implications of lamivudine resistance by HBV
19. HBV genotypic resistance to lamivudine in kidney recipients and hemodialyzed patients
20. Fulminant hepatic failure resulting from lamivudine-resistant hepatitis B virus in a renal transplant recipient